Laurion Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$2.71M | – | 573 |
|
|
2024
Q1 | $2.71M | Sell |
50,000
-1,300
| -3% | -$66.2K | 0.02% | 318 |
|
|
2023
Q4 | $2.63M | Hold |
51,300
| – | – | 0.02% | 277 |
|
|
2023
Q3 | $2.98M | Sell |
51,300
-571,700
| -92% | -$35M | 0.02% | 313 |
|
|
2023
Q2 | $39.8M | Buy |
623,000
+600,000
| +2,609% | +$40.2M | 0.22% | 103 |
|
|
2023
Q1 | $1.59M | Buy |
+23,000
| New | +$1.62M | 0.01% | 285 |
|
|
2022
Q4 | – | Sell |
-200,000
| Closed | -$14.2M | – | 427 |
|
|
2022
Q3 | $14.2M | Hold |
200,000
| – | – | 0.08% | 162 |
|
|
2022
Q2 | $15.4M | Sell |
200,000
-40,900
| -17% | -$3.11M | 0.24% | 85 |
|
|
2022
Q1 | $17.6M | Buy |
240,900
+213,500
| +779% | +$14.3M | 0.22% | 78 |
|
|
2021
Q4 | $1.71M | Sell |
27,400
-206,400
| -88% | -$12.1M | 0.02% | 294 |
|
|
2021
Q3 | $13.8M | Buy |
+233,800
| New | +$15.4M | 0.06% | 240 |
|
|
2020
Q4 | – | Sell |
-75,000
| Closed | -$4.52M | – | 654 |
|
|
2020
Q3 | $4.52M | Sell |
75,000
-7,000
| -9% | -$421K | 0.05% | 227 |
|
|
2020
Q2 | $4.82M | Sell |
82,000
-577,300
| -88% | -$34.5M | 0.05% | 227 |
|
|
2020
Q1 | $36.8M | Buy |
659,300
+394,300
| +149% | +$24.1M | 0.4% | 58 |
|
|
2019
Q4 | $17M | Buy |
265,000
+65,000
| +33% | +$3.72M | 0.13% | 159 |
|
|
2019
Q3 | $10.1M | Buy |
+200,000
| New | +$9.4M | 0.08% | 236 |
|
|
2019
Q1 | – | Sell |
-200,000
| Closed | -$10.4M | – | 875 |
|
|
2018
Q4 | $10.4M | Sell |
200,000
-250,000
| -56% | -$13.4M | 0.18% | 145 |
|
|
2018
Q3 | $27.9M | Buy |
450,000
+250,000
| +125% | +$14.8M | 0.27% | 63 |
|
|
2018
Q2 | $11.1M | Hold |
200,000
| – | – | 0.09% | 206 |
|
|
2018
Q1 | $12.7M | Sell |
200,000
-360,000
| -64% | -$23.2M | 0.1% | 193 |
|
|
2017
Q4 | $34.3M | Hold |
560,000
| – | – | 0.17% | 132 |
|
|
2017
Q3 | $35.7M | Sell |
560,000
-376,300
| -40% | -$22M | 0.16% | 108 |
|
|
2017
Q2 | $52.2M | Buy |
936,300
+498,500
| +114% | +$27.1M | 0.29% | 69 |
|
|
2017
Q1 | $23.8M | Buy |
437,800
+265,500
| +154% | +$14.6M | 0.18% | 145 |
|
|
2016
Q4 | $10.1M | Buy |
+172,300
| New | +$9.42M | 0.1% | 213 |
|
|
2014
Q3 | – | Sell |
-535,000
| Closed | -$26M | – | 303 |
|
|
2014
Q2 | $26M | Buy |
535,000
+200,000
| +60% | +$9.86M | 0.55% | 54 |
|
|
2014
Q1 | $17.4M | Buy |
335,000
+291,400
| +668% | +$15.5M | 0.64% | 58 |
|
|
2013
Q4 | $2.32M | Sell |
43,600
-195,800
| -82% | -$9.97M | 0.08% | 108 |
|
|
2013
Q3 | $11.1M | Buy |
+239,400
| New | +$10.5M | 0.82% | 36 |
|
Other funds holding BMY
VCM
VPM
Laurion Capital Management's BMY Position: Q1 2026 in Review
Laurion Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 36,100 shares worth $2.19M. The stake represents 0.1% of the portfolio and ranks #202 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in BMY as recently as Q2 2024.
Laurion Capital Management first reported a position in BMY in Q3 2013 and has held it in 26 quarters since. The position peaked at $176M in Q1 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Laurion Capital Management held 36,100 shares of Bristol-Myers Squibb worth $2.19M as of Q1 2026.
- Bristol-Myers Squibb was a new Laurion Capital Management position in Q1 2026.
- Bristol-Myers Squibb made up 0.1% of Laurion Capital Management's portfolio in Q1 2026, its #202 holding.
- Laurion Capital Management first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 26 quarters since.
- Laurion Capital Management's Bristol-Myers Squibb position peaked at $176M in Q1 2020.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.